A phosphoproteomic signature in endothelial cells predicts vascular toxicity of tyrosine kinase inhibitors used in CML.

Blood Adv

Authors	Srila Gopal Qing Lu Joshua Man Wendy Baur Sitara Rao Lev Litichevskiy Malvina Papanastasiou Amanda Creech Katherine DeRuff James Mullahoo Adam Officer Shawn Egri Desiree Davison Jacob Jaffe Iris Jaffe
Keywords	Humans Proteomics Aniline Compounds Protein Kinase Inhibitors Nitriles Quinolines Phosphoproteins Leukemia, Myelogenous, Chronic, BCR-ABL Positive Human Umbilical Vein Endothelial Cells
Year of Publication	2018
Journal	Blood Adv
Volume	2
Issue	14
Pages	1680-1684
Date Published	2018 07 24
ISSN	2473-9537
DOI	10.1182/bloodadvances.2018020396
PubMed ID	30021779
PubMed Central ID	PMC6058230
Links
Grant list	U54 HG008097 / HG / NHGRI NIH HHS / United States